Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 47,500 shares at $50.09 ($1.8M) on 2026-03-13, disclosed to the SEC on 2026-03-16.
Seasonal sale ($1.8M) by President, CEO — this insider has traded SUPN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 12,500 | $0 | 0.0% |
| 2 | $50.09 | 24,138 | $1.2M | 68.6% |
| 3 | $51.00 | 10,742 | $548K | 31.1% |
| 4 | $51.75 | 120 | $6K | 0.4% |
| Total | $37.12 avg | 47,500 | $1.8M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |
| SUPN | SELL | 2025-09-30 | $983K | — | Filing → |